Histologic and serum risk markers for noncardia early gastric cancer

International Journal of Cancer

Volumn 115, Issue 3, 2005, Pages 463-469

  Shiotani, Akiko ^a   Iishi, Hiroyasu ^b   Uedo, Noriya ^b   Kumamoto, Mitutaka ^c   Nakae, Yukinori ^c   Ishiguro, Shingo ^b   Tatsuta, Masaharu ^b   Graham, David Y ^d  

^a WAKAYAMA UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c Aishinkai Nakae Hospital   (Japan)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Corpus dominant gastritis; Early gastric cancer; Gastrin 17; Intestinal metaplasia; Pepsinogen I

Indexed keywords

BIOLOGICAL MARKER; GASTRIN 17; PEPSINOGEN;

ADULT; AGED; ARTICLE; ATROPHIC GASTRITIS; CANCER LOCALIZATION; CANCER RISK; CARDIA; CASE CONTROL STUDY; CONTROLLED STUDY; EARLY CANCER; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GASTRITIS; GASTROSCOPY; HELICOBACTER PYLORI; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STOMACH ANTRUM; STOMACH CANCER;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENDOSCOPY; FEMALE; GASTRIC MUCOSA; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; MALE; METAPLASIA; PEPSINOGEN A; PEPSINOGEN C; PYLORIC ANTRUM; STOMACH NEOPLASMS;

EID: 18644377372     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20852     Document Type: Article

References (32)

1. Dixon MF. Prospects for intervention in gastric carcinogenesis: reversibility of gastric atrophy and intestinal metaplasia. Gut 2001;49:2-4.
2. Meining A, Morgner A, Miehlke S, Bayerdorffer E, Stolte M. Atrophy-metaplasia-dysplasia-carcinoma sequence in the stomach: a reality or merely a hypothesis? Best Pract Res Clin Gastroenterol 2001; 15:983-98.
3. Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19(Suppl 1):S37-43.
4. Correa P. Chronic gastritis as a cancer precursor. Scand J Gastroenterol 1984;104(Suppl):131-6.
5. Tahara E. Molecular biology of gastric cancer. World J Surg 1995;19:484-90.
6. Tahara E, Kuniyasu H, Yasui W, Yokozaki H. Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 1994;6(Suppl 1):S97-102.
7. Tahara E. Molecular mechanism of human stomach carcinogenesis implicated in Helicobacter pylori infection. Exp Toxicol Pathol 1998;50:375-8.
8. Hattori T. Development of adenocarcinomas in the stomach. Cancer 1986;57:1528-34.
9. Ectors N, Dixon MF. The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 1986;10:1271-7.
10. Hattori T, Sugihara H. The pathological sequence in the development of gastric cancer: I. Scand J Gastroenterol 1996;214(Suppl):34-5.
11. Fennerty MB. Gastric intestinal metaplasia on routine endoscopic biopsy. Gastroenterology 2003;125:586-90.
12. El-Zimaity HM, Ota H, Graham DY, Akamatsu T, Katsuyama T. Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer 2002;94:1428-36.
13. Samloff IM, Secrist DM, Passaro E Jr. A study of the relationship between serum group I pepsinogen levels and gastric acid secretion. Gastroenterology 1975;69:1196-200.
14. Samloff IM, Kleinman MS. A radial diffusion assay for pepsinogen and pepsin. Gastroenterology 1969;56:30-4.
15. Nomura AM, Stemmermann GN, Samloff IM. Serum pepsinogen I as a predictor of stomach cancer. Ann Intern Med 1980;93:537-40.
16. Asaka M, Kimura T, Kudo M, Takeda H, Mitani S, Miyazaki T, Miki K, Graham DY. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992;102:760-6.
17. Shiotani A, Nishioka S, Iguchi M, Yanaoka K, Okada K, Tamai H, Mantani Y, Itoh H, Graham DY. Duodenal erosions after eradication of Helicobacter pylori infection. Gastrointest Endosc 2001;54: 448-53.
18. Kikuchi S, Wada O, Miki K, Nakajima T, Nishi T, Kobayashi O, Inaba Y. Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults. Cancer 1994;73:2695-702.
19. Kitahara F, Kobayashi K, Sato T, Kojima Y, Araki T, Fujino MA. Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut 1999;44:693-7.
20. Varis K, Sipponen P, Laxen F, Samloff IM, Huttunen JK, Taylor PR, Heinonen OP, Albanes D, Sande N, Virtamo J, Harkonen M. Implications of serum pepsinogen I in early endoscopic diagnosis of gastric cancer and dysplasia. Helsinki Gastritis Study Group. Scand J Gastroenterol 2000;35:950-6.
21. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002;48:505-15.
22. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston. 1994. Am J Surg Pathol 1996;20:1161-81.
23. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-9.
24. Vaira D, Holton J, Menegatti M, Landi F, Ricci C, Ali A, Gatta L, Farinelli S, Acciardi C, Massardi B, Miglioli M. Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group. Gut 1998;43(Suppl 1):539-46.
25. Cassaro M, Rugge M, Gutierrez O, Leandro G, Graham DY, Genta RM. Topographic patterns of intestinal metaplasia and gastric cancer. Am J Gastroenterol 2000;95:1431-8.
26. El-Zimaity HM, Ramchatesingh J, Saeed MA, Graham DY. Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol 2001;54:679-83.
27. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
28. Satoh K, Kimura K, Taniguchi Y, Yoshida Y, Kihira K, Takimoto T, Kawata H, Saifuku K, Ido K, Takemoto T, Ota Y, Tada M, et al. Distribution of inflammation and atrophy in the stomach of Helicobacter pylori-positive and -negative patients with chronic gastritis. Am J Gastroenterol 1996;91:963-9.
29. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature. Cancer 1993;72:3174-8.
30. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003;98:735-9.
31. Muller J, Kirchner T, Muller-Hennelink HK. Gastric endocrine cell hyperplasia and carcinoid tumors in atrophic gastritis type A. Am J Surg Pathol 1987;11:909-17.
32. Vaananen H, Vauhkonen M, Helske T, Kaariainen I, Rasmussen M, Tunturi-Hihnala H, Koskenpato J, Sotka M, Turunen M, Sandstrom R, Ristikankare M, Jussila A, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003; 15:885-91.